Orexigen Therapeutics, a biotech that was one of a wave of companies bringing through weight-loss pills, has announced that it has filed for bankruptcy.
Orexigen Therapeutics, Inc. announced that Health Canada has completed its screening phase and accepted for review a New Drug Submission for marketing approval of Contrave®.